These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2509392)

  • 1. Experience in the treatment of localized carcinoma of the prostate by definitive external irradiation.
    Kuten A; Nitetzky S; Tatcher M; Cohen Y; Robinson E
    Int Urol Nephrol; 1989; 21(3):325-32. PubMed ID: 2509392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
    Perez CA; Michalski J; Brown KC; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous course of megavoltage radiotherapy for carcinoma of the prostate.
    Weshler Z; Gez E; Pfeffer MR; Ben-Yosef R; Loeventhal E; Fuks Z
    Isr J Med Sci; 1988; 24(9-10):580-3. PubMed ID: 3144515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
    Puthawala AA; Syed AM; Austin PA; Cherlow JM; Perley JM; Shanberg AM; Sawyer DE; Ingram JE; Baghdassarian R; Wachs BH; Perley JE; Londrc A; Espinoza-Ferrel T
    Cancer; 2001 Oct; 92(8):2084-94. PubMed ID: 11596024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transurethral resection of prostate prior to definitive irradiation for prostate cancer. Lack of correlation with treatment outcome.
    Anscher MS; Prosnitz LR
    Urology; 1991 Sep; 38(3):206-11. PubMed ID: 1887532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate.
    Perez CA; Lee HK; Georgiou A; Logsdon MD; Lai PP; Lockett MA
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):581-91. PubMed ID: 8330986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group.
    Lawton CA; Winter K; Byhardt R; Sause WT; Hanks GE; Russell AH; Rotman M; Porter A; McGowan DG; DelRowe JD; Pilepich MV
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):931-9. PubMed ID: 9276357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.
    Galalae RM; Kovács G; Schultze J; Loch T; Rzehak P; Wilhelm R; Bertermann H; Buschbeck B; Kohr P; Kimmig B
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):81-90. PubMed ID: 11777625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral pelvic lymphadenectomy, iridium 192 template, and external beam therapy for localized prostatic carcinoma: complications and results.
    Klein FA; Ali MM; Marks SE; Hackler RH
    South Med J; 1988 Jan; 81(1):27-31. PubMed ID: 3336796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
    Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation.
    Zagars GK; von Eschenbach AC; Johnson DE; Oswald MJ
    Cancer; 1987 Oct; 60(7):1489-99. PubMed ID: 3113715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up.
    Amdur RJ; Parsons JT; Fitzgerald LT; Million RR
    Radiother Oncol; 1990 Jul; 18(3):235-46. PubMed ID: 2120741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer.
    Morton JD; Peschel RE
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1153-7. PubMed ID: 3133328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
    Lawton CA; Winter K; Grignon D; Pilepich MV
    J Clin Oncol; 2005 Feb; 23(4):800-7. PubMed ID: 15681524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate.
    Perez CA; Garcia D; Simpson JR; Zivnuska F; Lockett MA
    Radiother Oncol; 1989 Sep; 16(1):1-21. PubMed ID: 2554371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate.
    Zagars GK; von Eschenbach AC; Johnson DE; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):701-9. PubMed ID: 3350725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No apparent benefit at 5 years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose.
    Martinez A; Galalae R; Gonzalez J; Mitchell C; Gustafson G; Kovacs G
    J Urol; 2003 Dec; 170(6 Pt 1):2296-301. PubMed ID: 14634400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
    Zagars GK; von Eschenbach AC; Ayala AG
    Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.